Opicapone
Opicapone is a potent inhibitor of catechol-O-methyltransferase (COMT). It inhibits rat peripheral COMT with ED₅₀ values below 1.4 mg/kg up to 6 h post-administration. It is approved for use as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease.
Product Specifications
Shipping Conditions
Gel Pack
Storage Conditions
-20ºC
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6238199-01 0.1 mL
FGFR1 (Fibroblast Growth Factor Receptor 1, BFGFR, CD331, CEK, FGFBR, FLG, FLJ99988, FLT2, HBGFR, KAL2, N-SAM) (MaxLight 750)
Sign In for Pricing
View Details 
MBS6238199-02 5x 0.1 mL
FGFR1 (Fibroblast Growth Factor Receptor 1, BFGFR, CD331, CEK, FGFBR, FLG, FLJ99988, FLT2, HBGFR, KAL2, N-SAM) (MaxLight 750)
Sign In for Pricing
View Details GTR15253127 1 Vial
Lentiviral mouse Akt1 shRNA (UAS) - Lentiviral mouse Akt1 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details